These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 2920034)
41. Characterization of a novel cross-linked lipase: impact of cross-linking on solubility and release from drug product. Hetrick EM; Sperry DC; Nguyen HK; Strege MA Mol Pharm; 2014 Apr; 11(4):1189-200. PubMed ID: 24606399 [TBL] [Abstract][Full Text] [Related]
48. Heterobifunctional reagents for cross-linking of sugar with protein. Ohnishi M; Sugimoto H; Yamada H; Imoto T; Zaitsu K; Ohkura Y Chem Pharm Bull (Tokyo); 1985 Feb; 33(2):674-8. PubMed ID: 4017112 [No Abstract] [Full Text] [Related]
49. Cysteine modification and cleavage of proteins with 2-methyl-N1-benzenesulfony-N4-bromoacetylquinonediimide. Holmes TJ; Lawton RG J Am Chem Soc; 1977 Mar; 99(6):1984-6. PubMed ID: 839018 [No Abstract] [Full Text] [Related]
50. Site-directed chemical modification and cross-linking of a monoclonal antibody using equilibrium transfer alkylating cross-link reagents. Liberatore FA; Comeau RD; McKearin JM; Pearson DA; Belonga BQ; Brocchini SJ; Kath J; Phillips T; Oswell K; Lawton RG Bioconjug Chem; 1990; 1(1):36-50. PubMed ID: 2095204 [TBL] [Abstract][Full Text] [Related]
51. Cross-linking of ribosomal proteins by 4-(6-formyl-3-3-azidophenoxy)butyrimidate, a heterobifunctional, cleavable cross-linker. Maassen JA Biochemistry; 1979 Apr; 18(7):1288-92. PubMed ID: 427114 [TBL] [Abstract][Full Text] [Related]
52. Use of new heterobifunctional reagent for radiometallic labeling of antibodies. Wang TS; Ng AK; Alsedairy S; Fawwaz RA; Hardy MA; Alderson PO NCI Monogr; 1987; (3):145-8. PubMed ID: 3821912 [TBL] [Abstract][Full Text] [Related]
53. Heterobifunctional cross-linking of a monoclonal antibody with 2-methyl-N1-benzenesulfonyl-N4-bromoacetylquinonediimide. Liberatore FA; Comeau RD; Lawton RG Biochem Biophys Res Commun; 1989 Feb; 158(3):640-5. PubMed ID: 2920034 [TBL] [Abstract][Full Text] [Related]